Mobilization of DNA transposable elements from lentiviral vectors
- PMID: 22016863
- PMCID: PMC3190313
- DOI: 10.4161/mge.1.2.17062
Mobilization of DNA transposable elements from lentiviral vectors
Abstract
With the Sleeping Beauty (SB) DNA transposon, a reconstructed Tc1/mariner element, as the driving force, DNA transposable elements have emerged as new gene delivery vectors with therapeutic potential. The bipartite transposon vector system consists of a transposon vector carrying the transgene and a source of the transposase that catalyzes transposon mobilization. The components of the system are typically residing on separate plasmids that are transfected into cells or tissues of interest. We have recently shown that SB vector technology can be successfully combined with lentiviral delivery. Hence, SB transposons are efficiently mobilized from HIV-based integrase-defective lentiviral vectors by the hyperactive SB100X transposase, leading to the genomic insertion of lentivirally delivered DNA in a reaction controlled by a nonviral integration machinery. This new technology combines the better of two vector worlds and leads to integration profiles that are significantly altered and potentially safer relative to conventional lentiviral vectors. In this short commentary, we discuss our recent findings and the road ahead for hybrid lentivirus-transposon vectors.
Figures

Similar articles
-
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.J Vis Exp. 2018 Jan 12;(131):56742. doi: 10.3791/56742. J Vis Exp. 2018. PMID: 29364270 Free PMC article.
-
Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.Mol Ther. 2011 Aug;19(8):1499-510. doi: 10.1038/mt.2011.47. Epub 2011 Apr 5. Mol Ther. 2011. PMID: 21468003 Free PMC article.
-
Hybrid lentivirus-transposon vectors with a random integration profile in human cells.Mol Ther. 2009 Jul;17(7):1205-14. doi: 10.1038/mt.2009.10. Epub 2009 Feb 24. Mol Ther. 2009. PMID: 19240688 Free PMC article.
-
Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.Methods. 2009 Nov;49(3):287-97. doi: 10.1016/j.ymeth.2009.07.001. Epub 2009 Jul 15. Methods. 2009. PMID: 19615447 Review.
-
Sleeping Beauty Transposition.Microbiol Spectr. 2015 Apr;3(2):MDNA3-0042-2014. doi: 10.1128/microbiolspec.MDNA3-0042-2014. Microbiol Spectr. 2015. PMID: 26104705 Review.
Cited by
-
DNA transposon-based gene vehicles - scenes from an evolutionary drive.J Biomed Sci. 2013 Dec 9;20(1):92. doi: 10.1186/1423-0127-20-92. J Biomed Sci. 2013. PMID: 24320156 Free PMC article. Review.
-
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.J Vis Exp. 2018 Jan 12;(131):56742. doi: 10.3791/56742. J Vis Exp. 2018. PMID: 29364270 Free PMC article.
References
-
- Kay MA. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet. 2011;12:316–328. - PubMed
-
- Mates L, Chuah MK, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet. 2009;41:753–761. - PubMed
-
- Xue X, Huang X, Nodland SE, Mates L, Ma L, Izsvak Z, et al. Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood. 2009;114:1319–1330. - PubMed
LinkOut - more resources
Full Text Sources